---
figid: PMC7520695__JIR2020-2549763.002
figtitle: Canonical pathway and activation mechanism of inflammasomes and outcomes
  in cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7520695
filename: JIR2020-2549763.002.jpg
figlink: pmc/articles/PMC7520695/figure/fig2/
number: F2
caption: The canonical pathway and activation mechanism of inflammasomes and outcomes
  in cancer. PAMP and DAMP signals are recognized by PRRs/TLRs, which then lead to
  activation of caspases. Active caspase-1 will promote the IL-β and IL-18 release
  or pyroptosis initiation, through GSDMD cleavage and pore formation (image created
  in https://BioRender.com).
papertitle: 'Inflammation and Inflammasomes: Pros and Cons in Tumorigenesis.'
reftext: Liliana R. Balahura, et al. J Immunol Res. 2020;2020:2549763.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9171615
figid_alias: PMC7520695__F2
figtype: Figure
redirect_from: /figures/PMC7520695__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7520695__JIR2020-2549763.002.html
  '@type': Dataset
  description: The canonical pathway and activation mechanism of inflammasomes and
    outcomes in cancer. PAMP and DAMP signals are recognized by PRRs/TLRs, which then
    lead to activation of caspases. Active caspase-1 will promote the IL-β and IL-18
    release or pyroptosis initiation, through GSDMD cleavage and pore formation (image
    created in https://BioRender.com).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADSL
  - MYD88
  - NLRP3
  - STS
  - PYCARD
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - IL18
  - GSDMD
  - IL1A
  - IL1B
  - NFKB1
---
